1. Abstract Chronic liver disease in the clinical context is a disease process that causes progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
1. Abstract 1.1. Objective To explore the causal relationships between inflammatory factors and hepatic cancer and identify the role of serum metabolites as potential mediators.
1. Abstract 1.1. Background Two classical models have been proposed for the development of colorectal cancer (CRC) from colon epithelial cells.
1. Abstract Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is an uncommon but potentially life-threatening form of adverse drug reaction (ADR), most frequently reported with antiepileptics and antibiotics.
1. Abstract A 35-year-old woman was treated for complete dysphagia resulting from a chemical burn of the esophagus. Between 2012 and 2019, numerous interventional gastroscopies (4–16 per year) were performed to alleviate her sympoms.
1. Abstract 1.1. Background Although long-term antiviral therapy for chronic hepatitis B virus (HBV) can reverse fibrosis even in patients with liver cirrhosis, fibro sis progression can still occur despite viral suppression.
1. Abstract 1.1. Aim This study aimed to develop a predictive signature based on mitophagy-related lncRNAs to assess their prognostic and immunological significance in STAD patients.
1. Abstract 1.1. Objective This study aimed to use a randomised controlled trial to evaluate and compare the endoscopic morphological characteristics and patholog ic types of colorectal polyps between water-immersion and air-insufflation colonoscopy.
1. Introduction Cornelia de Lange Syndrome (CdLS) is a rare genetic disease (OMIM#122470, #300590, #300882, #614701, #610759), with a broad phenotypic spectrum, including congenital malformations, neurodevelopmental delay, intellectual disability, and behavioral disorders [1,2].
1. Abstract 1.1. Background Dementia is a progressive, neurodegenerative, terminal syndrome, that causes gradual decline of cognitive abilities that affects a per- son’s ability to perform daily activities. Patients with advanced de
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.